Nova Leap Health Corp. (TSXV:NLH)
Canada · Delayed Price · Currency is CAD 0.5900
+0.0300 (5.36%)
Aug 26, 2026, 11:31 AM EST
Nova Leap Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 33.6 | 31.47 | 25.76 | 26.18 | 28.21 | 21.28 | |
Revenue Growth | 19.53% | 22.15% | -1.60% | -7.18% | 32.55% | 22.93% |
Cost of Revenue | 20.19 | 18.98 | 15.87 | 16.41 | 18.23 | 14.07 |
Gross Profit | 13.41 | 12.48 | 9.89 | 9.77 | 9.98 | 7.21 |
Selling, General & Admin | 10.93 | 10.55 | 8.44 | 8.42 | 9.68 | 7.58 |
Operating Expenses | 11.69 | 11.38 | 9.02 | 9.31 | 11.04 | 8.44 |
Operating Income | 1.73 | 1.11 | 0.86 | 0.46 | -1.06 | -1.23 |
Interest Expense | -0.34 | -0.35 | -0.11 | -0.14 | -0.41 | -0.36 |
Currency Exchange Gain (Loss) | 0.55 | -0.76 | 1.31 | -0.4 | 0.93 | -0.07 |
Other Non Operating Income (Expenses) | - | - | -0.03 | -0.02 | -0.04 | -0.03 |
EBT Excluding Unusual Items | 1.94 | -0.01 | 2.04 | -0.11 | -0.58 | -1.69 |
Merger & Restructuring Charges | -0.08 | -0.12 | -0.26 | -0.11 | -0.26 | -0.34 |
Impairment of Goodwill | - | - | - | -1.5 | -0.51 | -0.61 |
Legal Settlements | - | - | - | 0.35 | - | - |
Other Unusual Items | - | - | 0.03 | - | 0.14 | 5.11 |
Pretax Income | 1.86 | -0.13 | 1.81 | -1.37 | -1.21 | 2.47 |
Income Tax Expense | 0.51 | 0.06 | 0.43 | -0.31 | -0.37 | 0.71 |
Net Income | 1.35 | -0.19 | 1.38 | -1.05 | -0.84 | 1.76 |
Net Income to Common | 1.35 | -0.19 | 1.38 | -1.05 | -0.84 | 1.76 |
Net Income Growth | 1060.31% | - | - | - | - | 40.15% |
Shares Outstanding (Basic) | 87 | 87 | 86 | 86 | 81 | 74 |
Shares Outstanding (Diluted) | 88 | 87 | 87 | 86 | 81 | 78 |
Shares Change | 1.09% | 0.60% | 0.68% | 5.83% | 4.90% | 16.89% |
EPS (Basic) | 0.02 | -0.00 | 0.02 | -0.01 | -0.01 | 0.02 |
EPS (Diluted) | 0.02 | -0.00 | 0.02 | -0.01 | -0.01 | 0.02 |
EPS Growth | 1016.64% | - | - | - | - | 3.67% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 2.05 | 1.56 | 1.36 | 2.13 | 0.95 | 2.18 |
Free Cash Flow Per Share | 0.02 | 0.02 | 0.02 | 0.03 | 0.01 | 0.03 |
Gross Margin | 39.92% | 39.67% | 38.38% | 37.31% | 35.37% | 33.89% |
Operating Margin | 5.14% | 3.52% | 3.35% | 1.76% | -3.77% | -5.79% |
Profit Margin | 4.01% | -0.60% | 5.35% | -4.03% | -2.96% | 8.27% |
Free Cash Flow Margin | 6.11% | 4.95% | 5.29% | 8.12% | 3.37% | 10.24% |
EBITDA | 2.14 | 1.59 | 1.14 | 0.99 | -0.07 | -0.56 |
EBITDA Margin | 6.36% | 5.06% | 4.43% | 3.80% | -0.24% | -2.65% |
D&A For EBITDA | 0.41 | 0.49 | 0.28 | 0.53 | 0.99 | 0.67 |
EBIT | 1.73 | 1.11 | 0.86 | 0.46 | -1.06 | -1.23 |
EBIT Margin | 5.14% | 3.52% | 3.35% | 1.76% | -3.77% | -5.79% |
Effective Tax Rate | 27.62% | - | 23.93% | - | - | 28.81% |